跳至主要内容
临床试验/NCT00000898
NCT00000898已完成不适用

A Prototype Study to Test the Effect of Staggered Dosing on the Pharmacokinetic Interactions Between Paired Combinations of Nelfinavir (NFV), Ritonavir (RTV), and Soft Gelatin Capsule of Saquinavir (SQVsgc)

National Institute of Allergy and Infectious Diseases (NIAID)4 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2001年8月31日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
4

研究概览

简要总结

The purpose of this study is to see if staggering doses of nelfinavir, ritonavir, and saquinavir has any effect on the interactions between these drugs.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients must have:
  • •Absence of HIV-1 infection as documented by any licensed ELISA test kit within 14 days prior to study entry.

排除标准

  • •Co-existing Condition:
  • •Patients with the following symptoms and conditions are excluded:
  • •Any medical condition that, in the opinion of the investigator, would interfere with the patient's ability to participate in this protocol.
  • •Patients with the following prior conditions and symptoms are excluded:
  • •History of chronic illness such as hypertension, coronary artery disease, arthritis, diabetes, or any chronic gastrointestinal conditions that might interfere with drug absorption.

研究者

申办方类型
Nih
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验